P2RY12 and diabetes mellitus: There were significant differences in previous coronary artery bypass grafting, DM, diagnosis on admission, trans-radial approach, coronary chronic total occlusion lesions, left ventricular ejection fraction, TG level, ABG level, HbA1c, SHR, insulin use, oral hypoglycaemic drug use, P2Y12 inhibitors use, and angiotensin-converting enzyme inhibitor/angiotensin receptor II antagonist use among the three groups (all p < 0.05) (Table 1).